Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-09 Sale | 2026-03-11 4:28 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 1,280 | $86.75 | $111,045 | 29,229 (Direct) | View |
| 2026-03-09 Sale | 2026-03-11 4:26 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 3,678 | $86.75 | $319,059 | 64,595 (Direct) | View |
| 2026-03-03 Purchase | 2026-03-05 7:19 pm | GeneDx Holdings Corp. | WGS | Meister Keith A. Corvex Management LP Director 10% Owner | 169,521 | $79.4 | $13,460,090 | 3,581,423 (Indirect Direct) | View |
| 2026-03-04 Sale | 2026-03-05 5:49 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 6,187 | $78.61 | $486,370 | 29,539 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 5:46 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 25,459 | $78.61 | $2,001,371 | 79,101 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 4:38 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 287 | $77.52 | $22,248 | 11,033 (Direct) | View |
| 2026-02-04 Sale | 2026-02-06 4:19 pm | GeneDx Holdings Corp. | WGS | Dechairo Bryan Chief Operating Officer | 5,961 | $85.7 | $510,874 | 0 (Direct) | View |
| 2026-02-02 Sale | 2026-02-03 7:30 pm | GeneDx Holdings Corp. | WGS | Dechairo Bryan Chief Operating Officer | 3,413 | $99.53 | $339,682 | 34,084 (Direct) | View |
| 2026-01-29 Sale | 2026-02-02 4:33 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 317 | $93.99 | $29,794 | 9,922 (Direct) | View |
| 2026-01-29 Sale | 2026-02-02 4:30 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 1,653 | $94 | $155,375 | 20,332 (Direct) | View |
| 2025-12-16 Sale | 2025-12-18 5:20 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 3,855 | $143.87 | $554,616 | 44,715 (Direct) | View |
| 2025-12-16 Sale | 2025-12-18 5:18 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 10,857 | $143.89 | $1,562,185 | 107,987 (Direct) | View |
| 2025-12-09 Sale | 2025-12-11 4:31 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 1,266 | $159.28 | $201,648 | 15,238 (Direct) | View |
| 2025-12-09 Sale | 2025-12-11 4:29 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 3,639 | $159.28 | $579,620 | 32,530 (Direct) | View |
| 2025-12-01 Sale | 2025-12-03 4:18 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 377 | $162.54 | $61,276 | 6,345 (Direct) | View |
| 2025-11-24 Sale | 2025-11-26 4:13 pm | GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director | 38,000 | $160.37 | $6,093,967 | 149,806 (Indirect Direct) | View |
| 2025-10-29 Sale | 2025-10-31 4:42 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 2,158 | $136.54 | $294,654 | 11,184 (Direct) | View |
| 2025-10-29 Sale | 2025-10-31 4:41 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 388 | $136.54 | $52,978 | 5,265 (Direct) | View |
| 2025-09-30 Sale | 2025-10-01 4:21 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 12,858 | $108.17 | $1,390,911 | 1,720 (Direct) | View |
| 2025-09-30 Sale | 2025-10-01 4:18 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 6,609 | $108.38 | $716,261 | 8,374 (Direct) | View |
| 2025-09-16 Sale | 2025-09-18 6:05 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 3,728 | $121.47 | $452,850 | 51,936 (Direct) | View |
| 2025-09-16 Sale | 2025-09-18 6:04 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 10,501 | $121.47 | $1,275,585 | 127,078 (Direct) | View |
| 2025-09-09 Sale | 2025-09-11 4:07 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,657 | $128.06 | $468,297 | 39,062 (Direct) | View |
| 2025-09-09 Sale | 2025-09-11 4:06 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 1,272 | $128.05 | $162,886 | 17,597 (Direct) | View |
| 2025-09-02 Sale | 2025-09-03 6:31 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 378 | $125.81 | $47,556 | 6,965 (Direct) | View |
| 2025-08-27 Sale | 2025-08-27 9:01 pm | GeneDx Holdings Corp. | WGS | Ryan Jason Director | 39,222 | $127.37 | $4,995,801 | 115,188 (Indirect Direct) | View |
| 2025-08-22 Sale | 2025-08-22 6:55 pm | GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli Director 10% Owner | 500,000 | $120.9 | $60,451,950 | 3,380,073 (Indirect Direct) | View |
| 2025-07-29 Sale | 2025-07-31 4:06 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 388 | $105.31 | $40,860 | 6,018 (Direct) | View |
| 2025-07-29 Sale | 2025-07-31 4:04 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,154 | $105.31 | $226,838 | 15,062 (Direct) | View |
| 2025-07-09 Sale | 2025-07-11 4:04 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 5,278 | $93 | $490,854 | 9,620 (Direct) | View |
| 2025-07-09 Sale | 2025-07-11 4:03 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,220 | $93 | $299,460 | 1,720 (Direct) | View |
| 2025-07-01 Sale | 2025-07-03 2:32 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 9,657 | $90.94 | $878,181 | 4,940 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-09 Exercise | 2026-03-11 4:28 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 2,462 | $0 | 29,229 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 4:26 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 6,546 | $0 | 64,595 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-09 07:56 am | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 1,986 | $88.11 | 20,660 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-09 07:54 am | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 3,404 | $88.11 | 42,087 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 5:50 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Dechairo Bryan Chief Operating Officer | 10,430 | $0 | 10,430 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 5:49 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 26,127 | $0 | 29,539 (Direct) | View |
| 2026-03-03 Option Award | 2026-03-05 5:46 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 88,102 | $0 | 79,101 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-03 4:38 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 718 | $0 | 11,033 (Direct) | View |
| 2026-02-01 Exercise | 2026-02-03 7:30 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Dechairo Bryan Chief Operating Officer | 9,374 | $0 | 34,084 (Direct) | View |
| 2026-01-29 Exercise | 2026-02-02 4:33 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 754 | $0 | 9,922 (Direct) | View |
| 2026-01-29 Exercise | 2026-02-02 4:30 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 3,874 | $0 | 20,332 (Direct) | View |
| 2025-12-16 Exercise | 2025-12-18 5:20 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 7,197 | $0 | 44,715 (Direct) | View |
| 2025-12-16 Exercise | 2025-12-18 5:18 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 18,750 | $0 | 107,987 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:31 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 2,462 | $0 | 15,238 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:29 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 6,547 | $0 | 32,530 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 4:18 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 717 | $0 | 6,345 (Direct) | View |
| 2025-10-29 Exercise | 2025-10-31 4:42 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 3,874 | $0 | 11,184 (Direct) | View |
| 2025-10-29 Exercise | 2025-10-31 4:41 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 753 | $0 | 5,265 (Direct) | View |
| 2025-09-30 Exercise | 2025-10-01 4:18 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 1,246 | $32.67 | 8,374 (Direct) | View |
| 2025-09-30 Exercise | 2025-10-01 4:18 pm | N/A 2032-08-31 | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 1,246 | $0 | 8,374 (Direct) | View |
| 2025-09-17 Option Award | 2025-09-19 4:11 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Fuchs Thomas Director | 3,438 | $0 | 3,438 (Direct) | View |
| 2025-09-16 Exercise(A) | 2025-09-18 9:50 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 7,197 | $0 | 12,483 (Direct) | View |
| 2025-09-16 Exercise | 2025-09-18 6:05 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 7,197 | $0 | 51,936 (Direct) | View |
| 2025-09-16 Exercise | 2025-09-18 6:04 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 18,750 | $0 | 127,078 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 4:07 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,546 | $0 | 39,062 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 4:06 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 2,462 | $0 | 17,597 (Direct) | View |
| 2025-09-01 Exercise | 2025-09-03 6:31 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 717 | $0 | 6,965 (Direct) | View |
| 2025-06-18 Option Award(A) | 2025-08-07 7:41 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Casdin Eli Director 10% Owner | 3,576 | $0 | 3,883,649 (Direct) | View |
| 2025-06-18 Exercise(A) | 2025-08-07 7:41 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Casdin Eli Director 10% Owner | 12,924 | $0 | 3,883,649 (Direct) | View |
| 2025-07-29 Exercise | 2025-07-31 4:06 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 753 | $0 | 6,018 (Direct) | View |
| 2025-07-29 Exercise | 2025-07-31 4:04 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,874 | $0 | 15,062 (Direct) | View |
| 2025-07-09 Exercise | 2025-07-11 4:04 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 1,245 | $32.67 | 9,620 (Direct) | View |
| 2025-07-09 Exercise | 2025-07-11 4:04 pm | N/A 2032-08-31 | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 1,245 | $0 | 9,620 (Direct) | View |